GRM8 and myeloid sarcoma: We chose GRM8 as it was associated with MS disease severity (Baranzini et al., 2009; Briggs et al., 2011), and we detected its regulatory network that was associated with neuroaxonal repair to be significantly elevated in pyramidal neurons of MS patients.